Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 803 results for "quest diagnostics"

Next Resistance Level for Quest Diagnostics (DGX) is $63.54

Shares of Quest Diagnostics (NYSE:DGX) opened today above their pivot of $63.05 and have already reached the first level of resistance at $63.30. Investors may be interested in a cross of the next upside pivot targets of $63.54 Individual.com, 17 hours ago

77 images for quest diagnostics

Tutorial Finder, 6 days ago
American Banking News, 2 weeks ago
Newsday, 4 days ago
ABC News 4 Charleston, 1 day ago
Newsday, 5 days ago
Occupational Health & Safety, 1 week ago
Caledonia Patch, 3 weeks ago
Newsday, 1 week ago
I Stock Analyst, 6 days ago
PR Newswire, 6 days ago

Quest Diagnostics (DGX) Trading Near $64.59 Resistance Level

After closing Tuesday at $63.52, Quest Diagnostics Inc (http://www.marketintelligencecenter.com/symbol/DGX"DGX) presents an attractive opportunity to get a 4.80% return in just 66 days, which is an annualized return of 26.57% (for comparison ...
 Individual.com2 days ago
ADVFN UK

Workforce drug test positivity rate increases for the first time in 10 years finds Quest Diagnostics

The percentage of positive drug tests among American workers has increased for the first time in more than a decade, fueled by a rise in the use of marijuana and amphetamines, according to drug test results released by Quest Diagnostics. Colorado ...
 HRnext1 day ago Quest Diagnostics Marks 10 Years on the Dow Jones Sustainability Index  TradingCharts.com2 days ago Worker Drug Test Positives Rise for First Time Since 2003  ERE.net1 week ago PERSONNEL MATTERS: Workforce drug test positives up">PERSONNEL MATTERS: Workforce drug test positives up  Tire Business1 week ago
[x]  
Seeking Alpha

Quest Diagnostics Offers A Good Long-Term Opportunity

Summary Quest Diagnostics Q2 FY2014 revenue from continuing operations grew 4.8% to $1.9 billion, while EPS grew 1.9% to $1.08. Quest Diagnostics has lowered its outstanding share count by 30% over the last 10 years. Quest Diagnostics and Lab ...
 Seeking Alpha1 week ago

Quest Diagnostics Shares Sinking Lower, Down 1.6%

One of today's notable stocks in decline is Quest Diagnostics (NYSE:DGX), down 1.6% to $62.83. The S&P is currently trading 0.3% higher to 1,995 and the Dow Jones Industrial Average is trading 0.3% higher
 Individual.com1 week ago Bearish Moving Average Cross by Quest Di...  Financial News Network online1 week ago
American Banking News

Goldman Sachs Made the Right Call, Quest Diagnostics 1.2% Higher (DGX)

A week ago, Goldman Sachs upgraded Quest Diagnostics from Buy to Conviction Buy. The shares closed at $63.83, or 1.2% over the $63.09 price of one
 Individual.com1 week ago Upgrade Alert for Quest Diagnostics (DGX)  TradingCharts.com2 weeks ago Quest Diagnostics Added To Goldman Sachs Conviction Buy List  Benzinga.com2 weeks ago Goldman Sachs Adds Quest Diagnostics (DGX) to CL-Buy List  Crawford Financial Planning2 weeks ago
[x]  

Potential Quest Diagnostics (DGX) Trade Has 2.73% Downside Protection

Quest Diagnostics Inc (http://www.marketintelligencecenter.com/symbol/DGX"DGX) presents a trading opportunity that offers a 4.28% return in just 74 days. A covered call on Quest Diagnostics at the $65.00 level expiring on Nov. '14 offers an ...
 Individual.com1 week ago

Expert Briefing on Health Care Sector Stocks - Edwards Lifesciences, Catamaran, Quest Diagnostics, Aetna, and WellPoint

/PRNewswire/ -- On Friday, September 12, 2014 , the NASDAQ Composite ended at 4,567.60, down 0.53%, the Dow Jones Industrial Average finished the day 0.36% lower at 16,987.51, and the S&P 500 closed at 1,985.54, down 0.60%. The losses were broad ...
 Tamar Securities4 days ago WellPoint : Expert Briefing on Health Care Sector Stocks - Edwards Lifesciences, Catamaran, Quest Diagnostics, Aetna, and WellPoint  4 Traders4 days ago
[x]  

Quest Diagnostics Rises 1.05% on Heavy Volume: Watch For Potential Pullback

Written on Wed, 09/03/2014 - 6:12pm By Nick Russo Quest Diagnostics ( NYSE:DGX ) traded in a range yesterday that spanned from a low of $63.62 to a high of $64.38. Yesterday, the shares gained 1.0%, which took the trading range above the ...
 Comtex SmarTrend2 weeks ago

Quest Diagnostics Q2 profit falls, but beats estimate

Quest Diagnostics (DGX), a provider of diagnostic testing information service, has announced a 19.39 percent decline in profit for the quarter ended Jun. 30, 2014. The company earned $133 million or $0.92 a share in the second-quarter compared with $165 ...
 Myiris1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less